The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ibandronic Acid Mylan 150 mg Film-coated Tablets

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/111/001

Main Information

Trade NameIbandronic Acid Mylan 150 mg Film-coated Tablets
Active SubstancesIbandronic sodium monohydrate
Dosage FormFilm-coated tablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/111/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA06 ibandronic acid


License statusAuthorised
Licence Issued02/07/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0141-062-003
Interchangeable List DocumentPDF of Interchangeable List
« Back